Logo image of DRMA

DERMATA THERAPEUTICS INC (DRMA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:DRMA - US2498455045 - Common Stock

2.2 USD
+0.08 (+3.77%)
Last: 1/14/2026, 8:00:01 PM
2.25 USD
+0.05 (+2.27%)
Pre-Market: 1/15/2026, 5:44:52 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
DRMA revenue by date.DRMA revenue by date.
N/AN/A
EBITDA
YoY % growth
DRMA ebitda by date.DRMA ebitda by date.
-4.469M-3.173M
29.01%
-7.857M
-147.65%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
DRMA ebit by date.DRMA ebit by date.
-4.471M-3.173M
29.03%
-7.857M
-147.63%
-9.675M
-23.13%
-8.042M
16.88%
-12.513M
-55.60%
N/A
36.16%
N/A
-23.42%
Operating Margin
DRMA operating margin by date.DRMA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DRMA eps by date.DRMA eps by date.
N/AN/AN/A-2,208.00
67.61%
-547.50
75.20%
-153.30
72.00%
N/A
94.68%
N/A
62.38%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.57
92.37%
-0.73
83.68%
-0.86
48.39%
-0.86
48.07%
-0.66
57.79%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-1.998M
37.56%
-2.186M
6.58%
-2.492M
-40.57%
-2.552M
-44.94%
-2.63M
-31.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.65
91.91%
-1.62-0.03-1.74%
Q2 2025
Q2Q % growth
-1.66
96.03%
-2.961.3043.88%
Q1 2025
Q2Q % growth
-4.50
93.62%
-4.590.091.96%
Q4 2024
Q2Q % growth
-20.60
34.60%
-15.30-5.30-34.64%
Q3 2024
Q2Q % growth
-20.40
74.81%
-26.936.5324.24%
Q2 2024
Q2Q % growth
-41.80
55.77%
-38.66-3.14-8.13%
Q1 2024
Q2Q % growth
-70.50
79.30%
-55.08-15.42-28.00%
Q4 2023
Q2Q % growth
-31.50
91.25%
-119.3487.8473.60%
Q3 2023
Q2Q % growth
-81.00
83.13%
-96.3915.3915.97%
Q2 2023
Q2Q % growth
-94.50
83.59%
-140.7646.2632.86%
Q1 2023
Q2Q % growth
-340.50
57.01%
-405.4564.9516.02%
Q4 2022
Q2Q % growth
-360.00
42.31%
-489.60129.6026.47%
Q3 2022
Q2Q % growth
-480.00
76.74%
-538.5658.5610.87%
Q2 2022
Q2Q % growth
-576.00
65.71%
-783.36207.3626.47%
Q1 2022
Q2Q % growth
-792.00 -979.20187.2019.12%
Q4 2021
Q2Q % growth
-624.00 -869.04245.0428.20%
Q3 2021
Q2Q % growth
-2,064.00 -1,126.08-937.92-83.29%
Q2 2021
Q2Q % growth
-1,680.00 -3,451.681,771.6851.33%
DRMA Yearly EPS VS EstimatesDRMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -2K -4K -6K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.67% 0% -3.09%
RevenueN/A N/A N/A N/A